Nu Q3 Earnings, Revenue Rise; Shares Fall After-Hours-March 2024-www.financetom.com

Nu Q3 Earnings, Revenue Rise; Shares Fall After-Hours

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nu Q3 Earnings, Revenue Rise; Shares Fall After-Hours

Nov 13, 2024 3:13 PM

05:45 PM EST, 11/13/2024 (MT Newswires) -- Nu Holdings ( NU ) reported Q3 earnings late Wednesday of $0.1132 per diluted share, up from $0.0624 a year earlier.

Analysts polled by Capital IQ expected $0.10.

Revenue for the quarter ended Sept. 30 rose to $2.94 billion from $2.14 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.95 billion.

The company's shares were down 2.8% in after-hours activity.

Previous page： CarMax Investor Starboard Value Nominates 2 Directors to Board Next page： BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CarMax Investor Starboard Value Nominates 2 Directors to Board

Mar 11, 2026

09:18 AM EDT, 03/11/2026 (MT Newswires) -- CarMax ( KMX ) activist investor Starboard Value said Wednesday that it has nominated two directors to the board and sent a letter identifying areas where management can drive improvement. Starboard, which has invested about $350 million in CarMax ( KMX ), said it sought to nominate Frontdoor Chief Executive William C. Cobb...

BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates

Mar 11, 2026

BrainsWay Ltd. ( BWAY ) reported fourth-quarter financial results on Wednesday ahead of the market open.BrainsWay Ltd. ( BWAY ) reported fourth-quarter financial results on Wednesday ahead of the market open. Here’s a look at the key details from the report. BrainsWay ( BWAY ) stock is trending lower. Why is BWAY stock falling? Q4 Financial Results BrainsWay ( BWAY )...

Wingstop Expands Stock Buyback Plan by $300 Million

Mar 11, 2026

09:21 AM EDT, 03/11/2026 (MT Newswires) -- Wingstop ( WING ) said Wednesday the board has approved the repurchase of up to another $300 million of its common shares. The company said it expects to finance the buybacks with existing cash and cash equivalents alongside anticipated cash flow from operations. ...

Biogen Says New Data Shows its Spinal Muscular Atrophy Drug Candidate Salanersen Slows Neurodegeneration

Mar 11, 2026

09:17 AM EDT, 03/11/2026 (MT Newswires) -- Biogen (BIIB) said Wednesday new data from an early-stage study showed its experimental spinal muscular atrophy drug salanersen slowed neurodegeneration and improved motor function in children. The company said the results were presented at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference. The phase 1b study tested the once-yearly therapy in 24...